Clinical Trials Browser

Phase 2 × Withdrawn × tivozanib × Clear all

NCT01834183 2013-06-19

Tivozanib + Gemcitabine in Metastatic RCC

Phase 2 Withdrawn

Carcinoma, Renal Cell, Neoplasm Metastasis